Skip to content
Screener

Price / sales at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
461.8×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.3×
Biogen logo
BiogenBIIB
3.2×+1.3×

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001689548-25-000111

FAQ

What is Praxis Precision Medicines, Inc.'s price / sales?
Praxis Precision Medicines, Inc. (PRAX) reported price / sales of 149.5× in Q3 2025.
How has Praxis Precision Medicines, Inc.'s price / sales changed year-over-year?
Praxis Precision Medicines, Inc.'s price / sales decreased by 76.5% year-over-year, from 636.6× to 149.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Praxis Precision Medicines, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude